INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Operating expenses
General and administrative	$ 1,116,014	$ 1,089,641	$ 2,242,198	$ 3,982,746
Research and development	2,492,933	1,090,527	4,535,423	2,729,856
Total operating expenses	(3,608,947)	(2,180,168)	(6,777,621)	(6,712,602)
Other income (expenses)
Grant income	16,684	26,879	51,970	65,934
Research and development incentive income	2,022,902		2,022,902	571,093
Interest income, net	18,147	2,064	21,802	4,206
Gain on settlement of accounts payable		151,402		151,402
Financing related charges and adjustments		(72)		(1,167)
Foreign exchange gain (loss)	11,722	(30,906)	25,804	(46,561)
Total other income, net	2,069,455	149,367	2,122,478	744,907
Net loss before provision for income taxes	(1,539,492)	(2,030,801)	(4,655,143)	(5,967,695)
Income tax expense - current	(9,595)		(40,603)	(17,615)
Net loss and comprehensive loss	$ (1,549,087)	$ (2,030,801)	$ (4,695,746)	$ (5,985,310)
Loss per share
Basic (in dollars per share)	$ (0.04)	$ (0.06)	$ (0.12)	$ (0.17)
Diluted (in dollars per share)	$ (0.04)	$ (0.06)	$ (0.12)	$ (0.17)
Weighted average number of shares outstanding
Basic (in shares)	41,159,707	35,214,793	39,761,612	34,589,957
Diluted (in shares)	41,159,707	35,214,793	39,761,612	34,589,957